Mini Review ARTICLE
Strain-dependent differences in corticolimbic processing of aversive or rewarding stimuli
- 1Dipartimento di Scienze Cliniche Applicate e Biotecnologie, Università degli Studi dell’Aquila, L’Aquila, Italy
- 2Santa Lucia Foundation, Rome, Italy
- 3Dipartimento di Psicologia and Centro ‘Daniel Bovet’, Sapienza Università di Roma, Rome, Italy
Aberrations in the elaboration of both aversive and rewarding stimuli characterize several psychopathologies including anxiety, depression and addiction. Several studies suggest that different neurotrasmitters, within the corticolimbic system, are critically involved in the processing of positive and negative stimuli. Individual differences in this system, depending on genotype, have been shown to act as a liability factor for different psychopathologies. Inbred mouse strains are commonly used in preclinical studies of normal and pathological behaviors. In particular, C57BL/6J (C57) and DBA/2J (DBA) strains have permitted to disclose the impact of different genetic backgrounds over the corticolimbic system functions. Here, we summarize the main findings collected over the years in our laboratory, showing how the genetic background plays a critical role in modulating amminergic and GABAergic neurotransmission in prefrontal-accumbal-amygdala system response to different rewarding and aversive experiences, as well as to stress response. Finally, we propose a top-down model for the response to rewarding and aversive stimuli in which amminergic transmission in prefrontal cortex (PFC) controls accumbal and amygdala neurotransmitter response.
Adaptive behavior involves the ability to represent the value of positive or negative stimuli, establish predictions about them, and use these predictions to guide behavior (O’Doherty, 2004). Animals and humans have a propensity to seek out rewards, avoid punishments, and cope with negative situations, such as stressful events. Aberrations in the elaboration of aversive and rewarding stimuli characterize several psychopathologies, including anxiety, depression, and addiction. For instance, disorders of mood and motivation are frequently associated with anhedonia (reduced ability to experience pleasure), and alterations in neural processing of rewarding and aversive stimuli have been recently proposed as an endophenotype of depression (Hasler et al., 2004; McCabe et al., 2009; Ventura et al., 2013). Thus, understanding the neural mechanisms by which positive and aversive stimuli are elaborated is critical for the development of therapeutic approaches for several psychopathologies.
Mood and motivation disorders and other psychiatric conditions have complicated etiologies and result from complex interactions between genetic and environmental precipitating factors. In psychobiology studies, inbred strains are a useful tool to investigate the role of genetic factors, in interaction with aversive and rewarding experiences, in susceptibility to development and expression of psychopathology. In particular, data from C57 and DBA have provided information on how the response of specific neuronal systems is related to genetic background.
The Use of the Inbred Strains
The use of inbred strains of mice offers great advantages to studies aimed to determine the function of neurotransmitter systems with regard to the effects of psychotropic drugs, stressful events, and various psychopathologies.
An inbred strain is a set of animals that is produced by at least 20 consecutive generations of sister-brother or parent-offspring matings and that can be traced to a single ancestral pair in the 20th or subsequent generations. Inbred animals are nearly entirely homozygous, providing a well-defined and consistent genotype for analysis. The genetic stability of inbred strains over the years and through laboratories has allowed myriad relevant information for several commonly used strains to be accumulated. Thus, comparative studies on neurotransmitter activity in various regions of the brain in inbred mouse strains, which have differences of behavioral outcomes, is one approach to investigate the neurochemical bases of behavioral expression. In any experimental procedure that involves laboratory-bred stocks, the results might reflect the strain and species that are used. There is a significant amount of data on differences in the effects of various experimental conditions against which the findings from inbred strains can be referenced, controlling the influence of this source of variability. Moreover, behavioral, pharmacological, physiological, and biochemical comparisons between inbred strains constitute a preliminary stage for more extensive genetic research, such as quantitative trait loci (QTL) analysis, to identify and map genes in mice. Such a strategy can facilitate extrapolation of the results to the human genome, due to the significant extent of the linkage homology between human and mouse (Plomin et al., 1991; Crabbe et al., 1994).
C57BL/6 and DBA/2 Strains
C57BL/6 (C57) and DBA/2 (DBA) mice are among the most frequently studied inbred strains with regard to psychobiology because their behavioral responses have strain-dependent differences. Moreover, the functional and anatomical characteristics of their brain neurotransmitter systems have been examined extensively in these strains. A wealth of data on various parameters, such as neurotransmitter metabolism and release, receptor density and distribution, and activity of second messengers, has been accumulated. Consequently, data collected in these strains can offer important indications about the relationship between the behavioral and central effects of different neurotransmitters and, more generally, the involvement of brain neurotransmitters in the control of behavior.
Clinical and preclinical studies suggest that the prefrontal cortex (PFC), striatum (including the nucleus accumbens (NAc)) and amygdala are activated by natural positive or negative salient stimuli, constituting a common substrate for processing rewarding and aversive stimuli (Berridge and Robinson, 1998; Becerra et al., 2001; Jensen et al., 2003; O’Doherty, 2004; Borsook et al., 2007). Aminergic and amino acid transmission are the principal modulatory mechanisms of the corticolimbic system, and the dysregulation of these systems is linked to alterations in the elaboration of aversive and rewarding stimuli underlying various psychopathologies.
The main findings collected over the years in our lab, by microdialysis experiments, have identified the role of several prefrontal cortex-accumbal-amygdala neurotransmitter systems in the elaboration of rewarding or aversive stimuli. Here we report findings from two experimental paradigms: place conditioning and forced swimming test (FST). The place conditioning paradigm permits to investigate the motivational salience attribution process to conditioned stimuli that are associated with primary rewarding and aversive events (Tzschentke, 1998; Reynolds and Berridge, 2002). The FST is one of paradigms most widely used to measure antidepressant activity of new drugs. Moreover, FST allows to assess alterations in depression-like behavior and coping response to stress in both normal and genetically modified animals (Porsolt et al., 1977; Borsini and Meli, 1988). The behavioral responses in the FST are thought to engage a coping strategy (Thierry et al., 1984), in which immobility behavior is an index of higher perceived motivational impact of a stressful experience. Finally, we used restraint stress to evaluate the time-dependent response induced by stress on different neurotransmitters in specific brain areas by intracerebral in vivo microdialysis.
Biological Basis of Processing Rewarding/Aversive Stimuli: Prefrontal-Amygdala-Accumbal System
The NAc, together with the PFC and amygdala, can be considered a component of the brain network that regulates effort-related functions (Salamone and Correa, 2012). The prefrontal-accumbal cathecolamine and system has been demonstrated to play a critical role in processing both rewarding and aversive stimuli (Ventura et al., 2007). Moreover, the amygdala is involved in Pavlovian conditioning of emotional responses and modulates memory for arousing experiences (Balleine, 2005; Balleine and Killcross, 2006; McGaugh, 2006), and a complex anatomical and functional connection between the amygdala, medial prefrontal cortex (mpFC), and NAc has been reported (Del Arco and Mora, 2009 for review). Studies showed a crucial role of mpFC/amygdala system in both processing of rewarding and coping to aversive stimuli, including stress conditions (Robinson and Berridge, 1993; Becerra et al., 2001; Gottfried et al., 2002; Jensen et al., 2003; Borsook et al., 2007; Andolina et al., 2013; Rudebeck et al., 2013). A growing body of evidence indicates that the prefrontal aminergic system controls both dopamine (DA) release in the NAc and GABA release in the amygdala, sub-cortical areas that mediate the elaboration of rewarding and aversive stimuli. Moreover, an alteration of this process seems to characterize several psychopathologies, including anxiety, depression, and addiction. Twin and adoption studies have demonstrated a gene-environment interaction in the development of psychiatric disorders, indicating that genetic background modulates the capacity of an environmental risk factor to give rise to mental illness (Caspi and Moffitt, 2006). In preclinical studies, inbred strains are a useful tool to investigate the role of genetic factors, in interaction with aversive and rewarding experiences, in susceptibility to development and expression of psychopathology. Indeed, comparative study of brain neurotransmitter activity and behavior in different genetic backgrounds is a major strategy for determining the neural basis of rewarding and aversive effects in relation to individual differences. In particular, the C57 and DBA strains have allowed us to determine the impact of genetic background on corticolimbic system function.
The principal function of DA in motivational salience processes and in the elaboration of rewarding stimuli has been widely reported (Robinson and Berridge, 2001). Thus, increased DA transmission in the NAc mediates the rewarding/reinforcing effects of addictive drugs (Di Chiara and Imperato, 1988; Wise and Rompre, 1989; Pontieri et al., 1995; Koob et al., 1998; Robbins and Everitt, 1999; Ventura et al., 2003, 2005, 2007). However, recent evidence suggests major involvement of brain norepinephrine (NE) in the behavioral and central effects of rewarding pharmacological and natural stimuli (Darracq et al., 1998; Tassin, 1998; Drouin et al., 2001; Zarrindast et al., 2002; Ventura et al., 2007; Latagliata et al., 2010; Puglisi-Allegra and Ventura, 2012). Ventura et al. demonstrated that selective prefrontal NE depletion in mice abolished the increase of DA in the NAc induced by various classes of drugs of abuse and food (Ventura et al., 2003, 2005, 2007, 2008; Latagliata et al., 2010). Moreover, these studies reported that an intact prefrontal cortical NE is necessary for Conditioned Place Preference (CPP) induced by amphetamine, morphine, cocaine, ethanol, and chocolate as well as for reinstatement (relapse) of extinguished morphine-induced CPP and for ethanol intake in a choice test (Ventura et al., 2003, 2005, 2006, 2007; Latagliata et al., 2010). Thus, they demonstrate that prefrontal NE transmission is crucial for accumbal DA release induced by pharmacological and natural rewarding stimuli and processing the rewarding/reinforcing effects of these stimuli. Finally, in addition to the prefrontal noradrenergic/accumbal dopaminergic neuronal circuit, different studies showed a crucial role of mpFC/amygdala system in processing of rewarding stimuli (Robinson and Berridge, 1993; Becerra et al., 2001; Gottfried et al., 2002; Borsook et al., 2007; Rudebeck et al., 2013).
Inter-individual differences have been frequently reported in the elaboration of both rewarding and aversive stimuli. Genotype-dependent control of corticolimbic neurotransmission could be responsible for individual differences in the elaboration of positive and aversive stimuli and thus be linked to different susceptibility to psychopathologies. Our findings in C57 and DBA mice support this hypothesis. Concerning the elaboration of rewarding stimuli, we showed differential effects of drugs of abuse (amphetamine), depending on genotype (Table 1). For instance, mice of DBA background are hyporesponsive to the behavioral effects of D-amphetamine, whereas C57 mice are highly responsive to the stimulating/reinforcing effects of amphetamine, as evidenced by increased locomotor activity, and amphetamine-induced CPP (Zocchi et al., 1998; Cabib et al., 2000; Ventura et al., 2004). Amphetamine produces lower prefrontal and higher accumbal DA levels, as well as higher locomotor activity, in C57 mice in comparison with DBA mice (Ventura et al., 2004). Moreover, selective prefrontal DA depletion in DBA mice leads to high DA outflow in the NAc and hyperlocomotion, comparable to those observed in C57 mice (Ventura et al., 2004). This evidence demonstrates that mesocortical DA controls the genotype-dependent effects of systemic amphetamine on mesoaccumbens DA release and locomotion. Nevertheless, as we have stressed, noradrenergic transmission in the mpFC has significant modulatory function on accumbal dopaminergic transmission and mediates the rewarding/reinforcing effects of addictive drugs. Because prefrontal DA inhibits NAc DA, whereas NE has been suggested to be enabling (Darracq et al., 1998), we hypothesized that an imbalance in NE/DA in the mpFC regulates DA in the NAc and the related behavioral outcomes, rendering the C57 strain more responsive than DBA. This hypothesis was confirmed by experiments that demonstrated that selective prefrontal cortical NE depletion abolishes the effects of amphetamine on DA in the accumbens and CPP in C57 mice (Ventura et al., 2003), whereas selective prefrontal DA depletion (sparing NE) leads to DA outflow in the NAc and behavioral outcomes in DBA mice, similar to those of C57 (Ventura et al., 2004, 2005). Thus, these evidences demonstrated that genotype-dependent susceptibility to the addictive properties of drugs of abuse (amphetamine) involves imbalanced DA and NE transmission in the mesocorticolimbic system.
Table 1. Summary of behavioral response and neurotrasmitter release to rewarding and aversive stimuli shown by C57 and DBA mice.
Aversive pharmacological and natural experiences, such as lithium and stress administration, have been shown to activate the same prefrontal cortical-subcortical network affected by rewarding stimuli (Pascucci et al., 2007; Ventura et al., 2007, 2008). In fact, the authors observed that natural and pharmacological aversive stimuli induce a clear-cut increase of NE in the mpFC and DA in the NAcs that was abolished by selective prefrontal NE depletion (Ventura et al., 2007, 2008). Results concerning natural, non-pharmacological aversive experiences (restraint stress) have demonstrated the same prefrontal noradrenergic control on accumbal DA outflow in rats (Pascucci et al., 2007). This study showed that exposure to a novel stressor (restraint) promotes a rapid, massive, and transient increase in NE release in the mpFC, paralleling the rise in mesoaccumbens DA release (Pascucci et al., 2007). Selective prefrontal NE depletion prevents both the cortical NE response and the increase in accumbens DA release, thus confirming the modulatory function of prefrontal NE transmission in accumbal DA transmission induced also by aversive stimuli. All together, these data demonstrate that catecholaminergic transmission in the neural circuit comprising NAc and mpFC is crucial in both stress response and processing of negative and positive stimuli (Cabib et al., 1988; Le Moal and Simon, 1991; Pascucci et al., 2007; Ventura et al., 2007, 2013; Cabib and Puglisi-Allegra, 2012).
In addition to the mpFC noradrenergic/accumbal dopaminergic neuronal circuit, other brain areas and neurotransmitters, such amygdala GABAergic transmission, are likely to be engaged in these processes. Concerning the prefrontal-amygdala system, we have recently showed that amygdalar GABA regulation by prefrontal 5-HT is critical for processing stressful experiences and for determining passive coping outcomes, as measured by FST in mice (Andolina et al., 2013). We have demonstrated that a stressful experience, such as restraint, increases 5-HT levels in the mpFC and GABA levels in the amygdala and that selective depletion of cortical 5-HT canceled out these stress-induced responses, implicating prefrontal 5-HT in the control of GABAergic transmission in the amygdala during stress exposure. Sustained stress-induced 5-HT outflow in the mpFC and GABA outflow in the basolateral amygdala (BLA) lead to sustained immobility. However, a disconnection between prefrontal 5-HT and amygdalar (BLA) GABAergic transmission leads to low immobility in the FST (Andolina et al., 2013). These results highlight other critical neural mechanisms in the perceived motivational impact of stressful experiences in which the prefrontal/amygdala connectivity mediated by 5-HT and GABA transmission has a significant function. Concerning data from inbred strains of mice, our restraint and FST results in C57 and DBA mice showed a genotype control of corticolimbic neurotransmission (Table 1). We found that restraint stress inhibited mesoaccumbens DA release, which was accompanied by rapid and strong activation of mesocortical DA metabolism in C57 mice; the opposite pattern occurred in DBA mice, thus demonstrating genetic control over the balance between mesocortical and mesoaccumbens DA responses to stress (Ventura et al., 2001). Moreover, C57 but not DBA mice experienced high immobility in their first session of the FST and immediate and robust activation of mesocortical DA metabolism and inhibition of mesoaccumbens DA metabolism and release. In addition, the behavioral and mesoaccumbens DA responses to FST in C57 mice were reduced and reversed, respectively, by selective dopamine DA depletion in the mpFC (Ventura et al., 2002). These studies showed that, as with rewarding stimuli, the genetic background governs the susceptibility to stressful experiences through the mesocortical-limbic DA response.
Another important neural network mediating stress responses is the mpFC-amygdala circuit that has been shown to be influenced by genotype (Holmes, 2008 for review). Specifically, consistent with the evidence that we have discussed, C57 mice have been reported to display greater immobility in the FST compared to DBA mice (Alcaro et al., 2002; Ventura et al., 2002). DBA and C57 mice are characterized by a different prefrontal 5-HT (Calcagno et al., 2007; Andolina et al., in press). In particular, DBA mice present lower 5-HT transporter binding and lower immobility in the FST than C57 (Sugimoto et al., 2008; Popova et al., 2009). Moreover, DBA mice are homozygous for the 1473G allele TPH-2, linked to low 5-HT synthesis rate, while C57BL/6 mice are homozygous for the 1473C allele. This allelic variant in DBA causes lower brain 5-HT synthesis than in C57BL/6 mice carrying the “C” allele (Zhang et al., 2004; Cervo et al., 2005). Moreover, differences between C57 and DBA mice have been reported for amygdala functioning which have been linked to strain-dependent difference in stress responsiveness (DuBois et al., 2006; Yang et al., 2008; Mozhui et al., 2010). Consistent with the evidences that genetic variation in cortico-amygdala system contributes to individual differences in stress response and to stress-related behavior, recently we reported that C57 mice show higher 5-HT outflow in the mpFC and higher GABA outflow in the BLA induced by stress (restraint) compared with the DBA strain. (Andolina et al., in press).
All together, these data indicate that strain-dependent prefrontal corticolimbic regulation, probably through different neurotransmitter systems including NE, DA, 5-HT, and GABA determines the differences in stress-coping behaviors in the FST in C57 and DBA mice.
The evidences that we have discussed demonstrate that neurotransmission in the neural circuit comprising PFC, NAcs, and amygdala, is crucial for processing rewarding and aversive stimuli. Moreover, data on C57 and DBA strains demonstrate how the genetic background determines the intensity and effects of the response to positive and negative stimuli. Most of the experiments that we have discussed above describe how selective NE, DA, or 5-HT depletion in mpFC modifies the neurotransmitter response of subcortical structures, such as the NAc and amygdala. PFC sends glutamatergic outputs to subcortical areas, including the NAc and amygdala, that mediate motor, emotional, and mnemonic function. In a top-down model, alterations in PFC neurotransmission could modify the function of specific PFC cellular networks (Yang and Chen, 2005; Del Arco and Mora, 2009) and, consequently, the function of subcortical structures, including the NAc and amygdala. This could lead to the development of abnormal behaviors associated with psychiatric disorders, such as depression, anxiety, and addiction. Our data support this model, wherein the aminergic system in the mpFC has a central role in dopaminergic and GABAergic neurotransmission in the NAc and amygdala, respectively. Furthermore, our findings support a model of genotype-dependent control of the prefrontal-accumbal-amygdala neural circuit, which could mediate the differential behavioral responses to many natural and pharmacological rewarding and aversive stimuli.
Conflict of Interest Statement
The Review Editor Antonella Gasbarri declares that, despite being affiliated to the same institution as author Diego Andolina, the review process was handled objectively and no conflict of interest exists. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We thank Dr Sergio Papalia for his skillful assistance.
This research was supported by “Ricerca Corrente”, Italian Ministry of Health and Ateneo 2012, Sapienza University of Rome and by Ministero della Ricerca Scientifica e Tecnologica (FIRB 2010).
Alcaro, A., Cabib, S., Ventura, R., and Puglisi-Allegra, S. (2002). Genotype and experience dependent susceptibility to depressive-like responses in the forced-swimming test. Psychopharmacology (Berl) 164, 138–143. doi: 10.1007/s00213-002-1161-8
Andolina, D., Maran, D., Valzania, A., Conversi, D., and Puglisi-Allegra, S. (2013). Prefrontal/amygdalar system determines stress coping behavior through 5-HT/GABA connection. Neuropsychopharmacology 38, 2057–2067. doi: 10.1038/npp.2013.107
Andolina, D., Maran, D., Viscomi, M. T., and Puglisi-Allegra, S. (in press). Strain dependent variations in stress coping behavior are mediated by a 5-HT/GABA interaction within the prefrontal corticolimbic system. Int. J. Neuropsychopharmacol. doi: 10.1093/ijnp/pyu074
Berridge, K. C., and Robinson, T. E. (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Brain Res. Rev. 28, 309–369. doi: 10.1016/s0165-0173(98)00019-8
Borsook, D., Becerra, L., Carlezon, W. A. Jr., Shaw, M., Renshaw, P., Elman, I., et al. (2007). Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders. Eur. J. Pain 11, 7–20. doi: 10.1016/j.ejpain.2005.12.005
Cabib, S., Kempf, E., Schleef, C., Oliverio, A., and Puglisi-Allegra, S. (1988). Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: role of genotype and stress duration. Brain. Res. 441, 153–160. doi: 10.1016/0006-8993(88)91393-5
Cabib, S., Orsini, C., Le Moal, M., and Piazza, P. V. (2000). Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 289, 463–465. doi: 10.1126/science.289.5478.463
Calcagno, E., Canetta, A., Guzzetti, S., Cervo, L., and Invernizzi, R. W. (2007). Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity. J. Neurochem. 103, 1111–1120. doi: 10.1111/j.1471-4159.2007.04806.x
Cervo, L., Canetta, A., Calcagno, E., Burbassi, S., Sacchetti, G., Caccia, S., et al. (2005). Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression. J. Neurosci. 25, 8165–8172. doi: 10.1523/jneurosci.1816-05.2005
Del Arco, A., and Mora, F. (2009). Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders. J. Neural Transm. 116, 941–952. doi: 10.1007/s00702-009-0243-8
Di Chiara, G., and Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U S A 85, 5274–5278. doi: 10.1073/pnas.85.14.5274
Drouin, C., Blanc, G., Trovero, F., Glowinski, J., and Tassin, J. P. (2001). Cortical alpha1-adrenergic regulation of acute and sensitized morphine locomotor effects. Neuroreport 12, 3483–3486. doi: 10.1097/00001756-200111160-00022
DuBois, D. W., Perlegas, A., Floyd, D. W., Weiner, J. L., and McCool, B. A. (2006). Distinct functional characteristics of the lateral/basolateral amygdala GABAergic system in C57BL/6J and DBA/2J mice. J. Pharmacol. Exp. Ther. 318, 629–640. doi: 10.1124/jpet.105.100552
Gottfried, J. A., O’Doherty, J., and Dolan, R. J. (2002). Appetitive and aversive olfactory learning in humans studied using event-related functional magnetic resonance imaging. J. Neurosci. 22, 10829–10837.
Jensen, J., McIntosh, A. R., Crawley, A. P., Mikulis, D. J., Remington, G., and Kapur, S. (2003). Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron 40, 1251–1257. doi: 10.1016/s0896-6273(03)00724-4
Koob, G. F., Roberts, A. J., Schulteis, G., Parsons, L. H., Heyser, C. J., Hyytiä, P., et al. (1998). Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin. Exp. Res. 22, 3–9. doi: 10.1111/j.1530-0277.1998.tb03611.x
Latagliata, E. C., Patrono, E., Puglisi-Allegra, S., and Ventura, R. (2010). Food seeking in spite of harmful consequences is under prefrontal cortical noradrenergic control. BMC Neurosci. 8, 11–15. doi: 10.1186/1471-2202-11-15
Mozhui, K., Karlsson, R. M., Kash, T. L., Ihne, J., Norcross, M., Patel, S., et al. (2010). Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J. Neurosci. 30, 5357–5367. doi: 10.1523/jneurosci.5017-09.2010
Pascucci, T., Ventura, R., Latagliata, E. C., Cabib, S., and Puglisi-Allegra, S. (2007). The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine. Cereb. Cortex 17, 2796–2804. doi: 10.1093/cercor/bhm008
Plomin, R., McClearn, G. E., Gora-Maslak, G., and Neiderhiser, J. M. (1991). Use of quantitative recombinant inbred strains to detect quantitative trait loci associated with behavior. Behav. Genet. 21, 99–116. doi: 10.1007/bf01066330
Pontieri, F. E., Tanda, G., and Di Chiara, G. (1995). Intravenous cocaine, morphine and amphetamine preferentially increase extracellular dopamine in the “shell” as compared with the “core” of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U S A 92, 12304–12308. doi: 10.1073/pnas.92.26.12304
Popova, N. K., Naumenko, V. S., Tibeikina, M. A., and Kulikov, A. V. (2009). Serotonin transporter, 5-HT1A receptor and behavior in DBA/2J mice incomparison with four inbred mouse strains. J. Neurosci. Res. 87, 3649–3657. doi: 10.1002/jnr.22155
Puglisi-Allegra, S., and Ventura, R. (2012). Prefrontal/accumbal catecholamine system processes emotionally driven attribution of motivational salience. Rev. Neurosci. 23, 509–526. doi: 10.1515/revneuro-2012-0076
Reynolds, S. M., and Berridge, K. C. (2002). Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste “liking”/“disliking” reactions, place preference/avoidance and fear. J. Neurosci. 22, 7308–7320.
Robinson, T. E., and Berridge, K. C. (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain. Res. Rev. 18, 247–291. doi: 10.1016/0165-0173(93)90013-p
Rudebeck, P. H., Mitz, A. R., Chacko, R. V., and Murray, E. A. (2013). Effects of amygdala lesions on reward-value coding in orbital and medial prefrontal cortex. Neuron 80, 1519–1531. doi: 10.1016/j.neuron.2013.09.036
Sugimoto, Y., Kajiwara, Y., Hirano, K., Yamada, S., Tagawa, N., Kobayashi, Y., et al. (2008). Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Eur. J. Pharmacol. 592, 116–122. doi: 10.1016/j.ejphar.2008.07.005
Tassin, J. P. (1998). Norepinephrine-dopamine interactions inthe prefrontal cortex and the ventral tegmental area: relevance to mental diseases. Adv. Pharmacol. 42, 712–716. doi: 10.1016/s1054-3589(08)60847-9
Thierry, B., Steru, L., Chermat, R., and Simon, P. (1984). Searching-waiting strategy: a candidate for an evolutionary model of depression? Behav. Neural Biol. 41, 180–189. doi: 10.1016/s0163-1047(84)90555-7
Tzschentke, T. M. (1998). Measuring reward with the conditioned place preferente paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56, 613–672. doi: 10.1016/s0301-0082(98)00060-4
Ventura, R., Alcaro, A., Cabib, S., Conversi, D., Mandolesi, L., and Puglisi-Allegra, S. (2004). Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Neuropsychopharmacology 29, 72–80. doi: 10.1038/sj.npp.1300300
Ventura, R., Alcaro, A., and Puglisi-Allegra, S. (2005). Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens. Cereb. Cortex 15, 1877–1886. doi: 10.1093/cercor/bhi066
Ventura, R., Cabib, S., Alcaro, A., Orsini, C., and Puglisi-Allegra, S. (2003). Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J. Neurosci. 23, 1879–1885.
Ventura, R., Cabib, S., and Puglisi-Allegra, S. (2002). Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral ‘despair’ in a mouse model of depression. Neuroscience 115, 999–1007. doi: 10.1016/s0306-4522(02)00581-x
Ventura, R., Coccurello, R., Andolina, D., Latagliata, E. C., Zanettini, C., Lampis, V., et al. (2013). Postnatal aversive experience impairs sensitivity to natural rewards and increases susceptibility to negative events in adult life. Cereb. Cortex 23, 1606–1617. doi: 10.1093/cercor/bhs145
Ventura, R., De Carolis, D., Alcaro, A., and Puglisi-Allegra, S. (2006). Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex. Neuroreport 17, 1813–1817. doi: 10.1097/01.wnr.0000239964.83566.75
Ventura, R., Latagliata, E. C., Morrone, C., La Mela, I., and Puglisi-Allegra, S. (2008). Prefrontal norepinephrine determines attribution of “high” motivational salience. PLoS One 3:e3044. doi: 10.1371/journal.pone.0003044
Ventura, R., Morrone, C., and Puglisi-Allegra, S. (2007). Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc. Natl. Acad. Sci. U S A 104, 5181–5186. doi: 10.1073/pnas.0610178104
Yang, C. R., and Chen, L. (2005). Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in Schizophrenia treatment. Neuroscientist 11, 452–470. doi: 10.1177/1073858405279692
Yang, R. J., Mozhui, K., Karlsson, R. M., Cameron, H. A., Williams, R. W., and Holmes, A. (2008). Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning. Neuropsychopharmacology 33, 2595–2604. doi: 10.1038/sj.npp.1301665
Zarrindast, M. R., Bahreini, T., and Adl, M. (2002). Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice. Pharmacol. Biochem. Behav. 73, 941–949. doi: 10.1016/s0091-3057(02)00951-6
Zocchi, A., Orsini, C., Cabib, S., and Puglisi-Allegra, S. (1998). Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice. Neuroscience 82, 521–528. doi: 10.1016/s0306-4522(97)00276-5
Keywords: strain, neurotransmission, corticolimbic, rewarding stimuli, stress
Citation: Andolina D, Puglisi-Allegra S and Ventura R (2015) Strain-dependent differences in corticolimbic processing of aversive or rewarding stimuli. Front. Syst. Neurosci. 8:207. doi: 10.3389/fnsys.2014.00207
Received: 18 June 2014; Accepted: 02 October 2014;
Published online: 04 February 2015.
Edited by:Maria V. Sanchez-Vives, ICREA-IDIBAPS, Spain
Reviewed by:Antonella Gasbarri, University of l’Aquila, Italy
Carmen Agustín-Pavón, Imperial College London, UK
Copyright © 2015 Andolina, Puglisi-Allegra and Ventura. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Diego Andolina, Dipartimento di Scienze Cliniche Applicate e Biotecnologie, Università degli Studi dell’Aquila, Via Vetoio, L’Aquila 67010, Italy e-mail: firstname.lastname@example.org;